Senior insider sale
Chief Executive Officer at VIR BIOTECHNOLOGY, INC. — senior position signals high conviction
$141.9K
19.04K shares
What this filing means
DE BACKER MARIANNE plans to sell 19.04K shares of VIR BIOTECHNOLOGY, INC. valued at approximately $141.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/23/2026ACC: 0001959173-26-001361
DirectorOfficer· Chief Executive Officer
Since Feb 2026
19.04K
Shares to sell
$141.9K
Approx. market value
19.04K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/23/2026
19.04KTotal acquired19.04K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/23/2026 | Restricted Stock Vesting Compensation | 19.04K | — |
| Total | 19.04K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
19.04K
Market value
$141.9K
2/23/2026
Total
Units
19.04K
Value
$141.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/23/2026 | 19.04K | $141.9K | NASDAQ | Planned |
| Total | 19.04K | $141.9K | ||